Showing results 18 to 29 of 29
< previous
| Issue Date | Title | Author(s) |
| 1-Jul-2011 | Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis | McNab, FW; Berry, MPR; Graham, CM; Bloch, SAA; Oni, T, et al |
| 3-Feb-2017 | Signatures of malaria-associated pathology revealed by high-resolution whole-blood transcriptomics in a rodent model of malaria. | Lin, JW; Sodenkamp, J; Cunningham, D; Deroost, K; Tshitenge, TC, et al |
| 1-Jan-2012 | Systems Biology Approaches Reveal a Specific Interferon-Inducible Signature in HTLV-1 Associated Myelopathy | Tattermusch, S; Skinner, JA; Chaussabel, D; Banchereau, J; Berry, MP, et al |
| 10-Jul-2017 | T Cell-Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection | Moreira-Teixeira, L; Redford, PS; Stavropoulos, E; Ghilardi, N; Maynard, CL, et al |
| 5-Oct-2016 | The Transcriptional Signature of Active Tuberculosis Reflects Symptom Status in Extra-Pulmonary and Pulmonary Tuberculosis | Blankley, S; Graham, CM; Turner, J; Berry, MPR; Bloom, CI, et al |
| 1-Nov-2018 | The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis | Singhania, A; Wilkinson, RJ; Rodrigue, M; Haldar, P; O'Garra, A |
| 5-Aug-2013 | Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers | Bloom, CI; Graham, CM; Berry, MPR; Rozakeas, F; Redford, PS, et al |
| 28-Jun-2019 | Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases | Singhania, A; Graham, CM; Gabrysova, L; Moreira-Teixeira, L; Stavropoulos, E, et al |
| 2020 | Transcriptomic analysis reveals diverse gene expression changes in airway macrophages during experimental allergic airway disease. | Branchett, WJ; O'Garra, A; Lloyd, CM |
| 7-Dec-2021 | Transcriptomic characterization of tuberculous sputum reveals a host Warburg effect and microbial cholesterol catabolism | Lai, RP-J; Cortes, T; Marais, S; Rockwood, N; Burke, M, et al |
| 2-Dec-2016 | Type I IFN inhibits alternative macrophage activation during Mycobacterium tuberculosis infection and leads to enhanced protection in the absence of IFN-gamma signaling | Moreira-Teixeira, L; Sousa, J; McNab, FW; Torrado, E; Cardoso, F, et al |
| 7-May-2018 | Type I interferons in tuberculosis: Foe and occasionally friend | Moreira-Teixeira, L; Mayer-Barber, K; Sher, A; O'Garra, A |